» Articles » PMID: 35020153

Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: Patient Demographics and In-hospital Outcomes

Overview
Publisher Springer
Date 2022 Jan 12
PMID 35020153
Authors
Affiliations
Soon will be listed here.
Citing Articles

Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review.

Saito Y, Kobayashi Y J Arrhythm. 2024; 40(5):1108-1114.

PMID: 39416245 PMC: 11474516. DOI: 10.1002/joa3.13128.


Gender Disparities in Japanese Interventional Cardiology: Outcomes of Female Operators in Percutaneous Coronary Interventions.

Takahashi S, Yamaji K, Kohsaka S, Hayashida K, Sato J, Tsukahara R JACC Asia. 2024; 4(9):674-683.

PMID: 39371622 PMC: 11450856. DOI: 10.1016/j.jacasi.2024.07.005.


Relationship between the number of drugs used during percutaneous coronary intervention and adverse events in patients with chronic coronary syndrome: Analysis of CLIDAS database.

Hitomi Y, Imai Y, Kuwabara M, Oba Y, Kabutoya T, Kario K Int J Cardiol Heart Vasc. 2024; 54:101507.

PMID: 39314922 PMC: 11417200. DOI: 10.1016/j.ijcha.2024.101507.


Relationship between body mass index and clinical events in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Yamazaki T, Kitahara H, Yamashita D, Sato T, Suzuki S, Hiraga T PLoS One. 2024; 19(9):e0309758.

PMID: 39298466 PMC: 11412652. DOI: 10.1371/journal.pone.0309758.


Impact of Cancer, Inflammation, and No Standard Risk Factors in Patients With Myocardial Infarction.

Yaginuma H, Saito Y, Goto H, Asada K, Shiko Y, Sato T JACC Asia. 2024; 4(7):507-516.

PMID: 39101117 PMC: 11291396. DOI: 10.1016/j.jacasi.2024.03.008.


References
1.
Sawano M, Yamaji K, Kohsaka S, Inohara T, Numasawa Y, Ando H . Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry. Cardiovasc Interv Ther. 2020; 35(3):218-226. PMC: 7295726. DOI: 10.1007/s12928-020-00669-z. View

2.
Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K . JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome. Circ J. 2019; 83(5):1085-1196. DOI: 10.1253/circj.CJ-19-0133. View

3.
Neumann F, Sousa-Uva M, Ahlsson A, Alfonso F, Banning A, Benedetto U . 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018; 40(2):87-165. DOI: 10.1093/eurheartj/ehy394. View

4.
Maron D, Hochman J, Reynolds H, Bangalore S, OBrien S, Boden W . Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020; 382(15):1395-1407. PMC: 7263833. DOI: 10.1056/NEJMoa1915922. View

5.
Ikari Y, Yamada S, Ehara N, Kozuma K, Shinke T, Sugano T . The Japanese Association of Cardiovascular Intervention and Therapeutics position statement on coronary invasive procedures during the COVID-19 pandemic in Japan. Cardiovasc Interv Ther. 2021; 36(2):139-144. PMC: 7982308. DOI: 10.1007/s12928-021-00767-6. View